- D59.19 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D59.19 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D59.19 – other international versions of ICD-10 D59.19 may differ.
ICD-10-CM D59.19 is grouped within Diagnostic Related Group(s):
- 808 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with mcc
- 809 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders with cc
- 810 Major hematological and immunological diagnoses except sickle cell crisis and coagulation disorders without cc/mcc
Code History
- 2021 (effective 10/1/2020): New code
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D59.19:
- Dyke-Young type (secondary) (symptomatic) > Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9
- autoimmune NEC > acquired D59.9
- Lederer\’s > acute D59.9
- Lederer\’s (hemolytic) > Anemia (essential) (general) (hemoglobin deficiency) (infantile) (primary) (profound) D64.9